The effect of disease-modifying antirheumatic drugs on vaccine immunogenicity in adults.
Where this comes from
- Record sourced from PubMed, PMID 33139263.
- Also identified by DOI 10.3949/ccjm.87a.20056.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patients with immunocompromising conditions are at higher risk of vaccine-preventable infections. Further, those receiving immunosuppressive disease-modifying antirheumatic drugs (DMARDs) can have variable responses to vaccines depending on which vaccine and which DMARD they are receiving.
Medical subject headings
- Antirheumatic Agents
- Immunocompromised Host
- Immunogenicity, Vaccine
- Immunosuppressive Agents
- Rheumatic Diseases
- Vaccines